Halozyme Therapeutics | HALO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
Amgen USD 195.44B 5.55B 2026-06
Baxter International USD 11.01B 2.34B 2026-06
Cara Therapeutics USD 30M 336M 2026-03
Cytokinetics USD 11.55B 3.36B 2026-06
DBV Technologies USD 1.23B 327M 2026-03
Eli Lilly USD 1.13T 260.54B 2026-06
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
MannKind USD 1.32B 559M 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Pfizer USD 138.44B 15.37B 2026-06
United Therapeutics USD 23B 2.19B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12